Sarcolemmal fatty acid uptake vs. mitochondrial beta-oxidation as target to regress cardiac insulin resistance.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme

• Publication date

  2009-05-12

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1139/H09-040PMID 19448717
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Etomoxir-induced partial carnitine palmitoyltransferase-I (CPT-I) inhibition in vivo does not alter cardiac long-chain fatty acid uptake and oxidation rates.

  2009cited by this paper
• Trimetazidine, a Metabolic Modulator, Has Cardiac and Extracardiac Benefits in Idiopathic Dilated Cardiomyopathy

  2008cited by this paper
• Thiazolidinedione insulin sensitizers and the heart: a tale of two organs?

  2008cited by this paper
• Regulation of sarcolemmal glucose and fatty acid transporters in cardiac disease.

  2008influential reference
• Cardiac contractile dysfunction in insulin-resistant rats fed a high-fat diet is associated with elevated CD36-mediated fatty acid uptake and esterification

  2007cited by this paper
• Cellular fatty acid transport in heart and skeletal muscle as facilitated by proteins

  2007cited by this paper
• Evidence for concerted action of FAT/CD36 and FABPpm to increase fatty acid transport across the plasma membrane.

  2007cited by this paper
• Metabolic syndrome and mitochondrial function: Molecular replacement and antioxidant supplements to prevent membrane peroxidation and restore mitochondrial function

  2007cited by this paper
• A null mutation in skeletal muscle FAT/CD36 reveals its essential role in insulin- and AICAR-stimulated fatty acid metabolism.

  2007cited by this paper
• Forgotten but not gone: the rediscovery of fatty heart, the most common unrecognized disease in America.

  2007cited by this paper
• Mechanisms responsible for enhanced fatty acid utilization by perfused hearts from type 2 diabetic db/db mice

  2007cited by this paper
• Metabolic mechanisms in heart failure.

  2007cited by this paper
• High-fat diet, muscular lipotoxicity and insulin resistance

  2007cited by this paper
• CD36: implications in cardiovascular disease.

  2007cited by this paper
• Cardiac overexpression of catalase rescues cardiac contractile dysfunction induced by insulin resistance: role of oxidative stress, protein carbonyl formation and insulin sensitivity

  2006cited by this paper
• Metabolic Therapeutics in Angina Pectoris: History Revisited with Perhexiline

  2006cited by this paper
• Bridging the GAP between insulin signaling and GLUT4 translocation.

  2006cited by this paper
• Myocardial substrate metabolism in the normal and failing heart.

  2005cited by this paper
• Fatty acid metabolism is enhanced in type 2 diabetic hearts.

  2005cited by this paper
• Divergent effects of rosiglitazone on protein-mediated fatty acid uptake in adipose and in muscle tissues of Zucker rats Published, JLR Papers in Press, March 16, 2005. DOI 10.1194/jlr.M400426-JLR200

  2005cited by this paper
• Long-chain fatty acid uptake and FAT/CD36 translocation in heart and skeletal muscle.

  2005cited by this paper
• Modeling of palmitate transport in the heart

  2004cited by this paper
• Regulation of fatty acid transport by fatty acid translocase/CD36

  2004cited by this paper
• Enhanced sarcolemmal FAT/CD36 content and triacylglycerol storage in cardiac myocytes from obese zucker rats.

  2004cited by this paper
• Peroxisome Proliferator Activator Receptors (PPAR), Insulin Resistance, and Cardiomyopathy: Friends or Foes for the Diabetic Patient With Heart Failure?

  2004cited by this paper
• Skeletal muscle lipid metabolism with obesity.

  2003cited by this paper
• The patient with diabetes mellitus and heart failure: at-risk issues.

  2003cited by this paper
• The Use of Partial Fatty Acid Oxidation Inhibitors for Metabolic Therapy of Angina Pectoris and Heart Failure

  2002cited by this paper
• Adaptation and maladaptation of the heart in diabetes: Part I: general concepts.

  2002influential reference
• Control of mitochondrial beta-oxidation flux.

  2002cited by this paper
• Increased protein kinase C theta in skeletal muscle of diabetic patients.

  2001cited by this paper
• Increased Rates of Fatty Acid Uptake and Plasmalemmal Fatty Acid Transporters in Obese Zucker Rats*

  2001cited by this paper
• Increased Myocardial Rab GTPase Expression: A Consequence and Cause of Cardiomyopathy

  2001cited by this paper
• Fatty acid import into mitochondria.

  2000influential reference
• Acyl-CoA inhibition of hexokinase in rat and human skeletal muscle is a potential mechanism of lipid-induced insulin resistance.

  2000cited by this paper
• Heterogeneity of pig intestinal D-glucose transport systems.

  1999cited by this paper
• Skeletal muscle fatty acid metabolism in association with insulin resistance, obesity, and weight loss.

  1999cited by this paper
• Skeletal muscle fatty acid metabolism in association with insulin resistance, obesity, and weight loss.

  1999cited by this paper
• Heterogeneity of pig intestinald-glucose transport systems.

  1999cited by this paper
• Ceramide Generation Is Sufficient to Account for the Inhibition of the Insulin-stimulated PKB Pathway in C2C12 Skeletal Muscle Cells Pretreated with Palmitate*

  1999cited by this paper
• Molecular mechanisms involved in GLUT4 translocation in muscle during insulin and contraction stimulation.

  1998cited by this paper
• Alterations in the expression and cellular localization of protein kinase C isozymes epsilon and theta are associated with insulin resistance in skeletal muscle of the high-fat-fed rat.

  1997cited by this paper
• The mitochondrial carnitine palmitoyltransferase system. From concept to molecular analysis.

  1997cited by this paper
• Alterations in the Expression and Cellular Localization of Protein Kinase C Isozymes ε and θ Are Associated With Insulin Resistance in Skeletal Muscle of the High-Fat–Fed Rat

  1997cited by this paper
• Cellular fatty acid-binding proteins: their function and physiological significance.

  1996cited by this paper
• Use of a selective inhibitor of liver carnitine palmitoyltransferase I (CPT I) allows quantification of its contribution to total CPT I activity in rat heart. Evidence that the dominant cardiac CPT I isoform is identical to the skeletal muscle enzyme.

  1994cited by this paper
• Malonyl-CoA metabolism in cardiac myocytes and its relevance to the control of fatty acid oxidation.

  1993cited by this paper
• Acetyl-CoA carboxylase regulation of fatty acid oxidation in the heart.

  1993cited by this paper
• THE GLUCOSE FATTY ACID CYCLE IN OBESITY AND MATURITY ONSET DIABETES MELLITUS

  1965cited by this paper
• On Diabetes: Insulin Resistance Cellular Mechanisms of Insulin Resistance

  year unknowncited by this paper

• Particulate matter inhalation and the exacerbation of cardiopulmonary toxicity due to metabolic disease

  2021cites this paper
• The role of CD36 in cardiovascular disease

  2020cites this paper
• Role of Oxidative Stress in Metabolic and Subcellular Abnormalities in Diabetic Cardiomyopathy

  2020cites this paper
• Vascular endothelial growth factor B promotes transendothelial fatty acid transport into skeletal muscle via histone modifications during catch-up growth.

  2020cites this paper
• Intracellular Reorganization of Cardiomyocytes in Dyslipidemic Cardiomyopathies

  2018cites this paper
• HEMODYNAMIC AND CARDIAC EFFECTS OF OBESITY AND THE METABOLIC SYNDROME

  2017cites this paper
• Cardiovascular consequences of metabolic syndrome.

  2017cites this paper
• Assessment of myocardial metabolic flexibility and work efficiency in human type 2 diabetes using 16-[18F]fluoro-4-thiapalmitate, a novel PET fatty acid tracer.

  2016cites this paper
• Vascular endothelial growth factor B-role in metabolism, lipotoxicity and disease

  2015cites this paper
• Good and bad consequences of altered fatty acid metabolism in heart failure: evidence from mouse models.

  2015influential citation
• Myocardial Lipid Profiling During Time Course of High Fat Diet and its Relationship to the Expression of Fatty Acid Transporters

  2015cites this paper
• Endothelial Growth Factor B Endothelial Fatty Acid Transport: Role of Vascular

  2013cites this paper
• Endothelial fatty acid transport: role of vascular endothelial growth factor B.

  2013cites this paper
• Mechanisms of subcellular remodeling in heart failure due to diabetes

  2013cites this paper
• Myocardial fatty acid metabolism and lipotoxicity in the setting of insulin resistance.

  2012cites this paper
• Regulation and Functions of Cardiac Lipins

  2012cites this paper
• Myocardial macronutrient transporter adaptations in the adult pregestational female intrauterine and postnatal growth-restricted offspring.

  2012cites this paper
• Shedding light on the enigma of myocardial lipotoxicity: the involvement of known and putative regulators of fatty acid storage and mobilization.

  2010cites this paper
• INHIBITION OF CHOLESTEROL SYNTHESIS BY POLICOSANOL

  2010cites this paper
• VASCULAR ENDOTHELIAL GROWTH FACTOR B - ROLE IN METABOLISM, LIPOTOXICITY AND DISEASE

  year unknowncites this paper